跳至主要内容
临床试验/NCT00224718
NCT00224718已完成不适用

ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal " Surgery Versus Endoprosthesis "

Assistance Publique - Hôpitaux de Paris2 个研究点 分布在 1 个国家目标入组 306 人开始时间: 2003年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
306
试验地点
2
主要终点
Death and major adverse events

研究概览

简要总结

Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a consensus to propose surgical repair in patients with a reasonable operative risk when the AAA exceeds 5 cm in diameter.

The aim of the study is to compare the mortality and the occurrence of severe general, vascular and local complications in two groups of patients treated by either by open surgery or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary endpoint are respectively the survival without severe complications and minor morbidity.

详细描述

ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal " Surgery Versus Endoprosthesis Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a consensus to propose surgical repair in patients with a reasonable operative risk when the AAA exceeds 5 cm in diameter.

The aim of the study is to compare the mortality and the occurrence of severe general, vascular and local complications in two groups of patients treated by either by open surgery or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary endpoint are respectively the survival without severe complications and minor morbidity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 50 years old or more (more than 80 possible depending on physiological age)
  • Level 0, 1, or 2 of operative risk
  • Abdominal aortic aneurysm with a diameter > or equal to 50 mm or > or equal to 40 mm if rapid growing (10 mm or more in a year), or painful, or saccular aneurysms, or aneurisms of common iliac arteries with a diameter equal or superior to 30 mm; or women with a diameter equal to 45 mm;
  • Aortic neck superior or equal to 1.5 cm
  • No stenosis superior or equal to 75% of the superior mesenteric artery
  • Proximal neck angulation inferior to 80°
  • Diameter of the iliac arteries compatible with introducer sheath
  • Inform consent signed

排除标准

  • Aneurysm involving the renal arteries or with the length of the neck less than 1.5 cm
  • Thrombus or major calcification in the neck
  • Diameter of the iliac arteries not compatible with introducer sheath
  • Level 3 of operative risk
  • History of major iodine allergy (Quincke oedema, anaphylactic shock)
  • Other comorbidity with life expectancy less than 6 months
  • Follow up impossible during the trial
  • Participation in another trial
  • Inform consent not signed

结局指标

主要结局

Death and major adverse events

时间窗: 4 years

次要结局

  • Minor adverse events (systemic vascular or non vascular complications)(4 years)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验